A fierce competition is unfolding in the American soybean market, with Corteva, a spin-off of DowDuPont, gaining ground against industry leader Bayer. As farmers weigh the flexibility of spraying ...

For the coming year the Bayer Carbon Program highlights six expanded opportunities for farmers to enroll in the program and earn incentives for regenerative practices. The company structures its ...

Bayer is launching a sweeping business overhaul as the German conglomerate sees “no viable alternative.” Bayer on Wednesday unveiled a restructuring of its organization that will “come at the expense ...

The Trump administration has diverged from the position of former US President Joe Biden, throwing its weight behind German ...

Bayer’s animal health selloff is finally here, as the German conglomerate restructures itself for future growth. Bayer has agreed to sell the animal health business to rival Elanco, an Eli Lilly ...

Faced with huge debt, the impending expiry of a crucial patent, and ongoing litigation over a horror acquisition, Bayer CEO Bill Anderson made a bold move a year ago to get his damaged company back on ...

Pharma giant Bayer is launching a precision health unit as it ramps up its investment in consumer-facing digital health tools. The company will prioritize developing products that enable people to ...

Bayer has cleared out four cancer candidates from its early-stage pipeline, including a STAT3 inhibitor acquired as part of its buyout of Vividion Therapeutics. The Vividion asset in question, called ...

The new medication reinforces Bayer Pakistan’s commitment to improving access to innovative therapies for women’s ...